This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2010-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2014
Title: **Euan Alexander Arnott: Innovator in Pharmaceutical Chemistry**
Introduction
Euan Alexander Arnott is a notable inventor based in Macclesfield, GB, with a proven track record in the field of pharmaceutical chemistry. With a total of two patents to his name, Arnott has made significant contributions through innovative processes in chemical manufacturing.
Latest Patents
Arnott's latest patents highlight his focus on the synthesis of complex chemical compounds. One of his notable inventions is the "Process for the manufacture of 4-fluoro-2-methyl-1H-indol-5-ol," which pertains to a specific chemical process for producing a compound of defined formula. Furthermore, his second patent covers a broader spectrum with the title "Chemical process," relating to the manufacture of particular quinazoline derivatives, including pharmaceutically acceptable salts. This invention also details intermediates useful in the synthesis of quinazoline derivatives, emphasizing the innovative steps, reagents, and conditions involved in the process.
Career Highlights
Euan Arnott is currently associated with AstraZeneca AB, a global leader in the pharmaceutical industry. His role at AstraZeneca allows him to apply his expertise in developing innovative chemical processes that can have significant impacts on drug development and manufacturing.
Collaborations
Throughout his career, Arnott has worked alongside esteemed colleagues, including John Crosby and James Gair Ford. This collaborative environment fosters innovation and allows for the exchange of ideas, enhancing the potential for groundbreaking discoveries in their field.
Conclusion
Euan Alexander Arnott stands out as an influential inventor in the realm of pharmaceutical chemistry. His patents not only demonstrate his commitment to innovation but also highlight the importance of collaboration in the research and development process. His contributions at AstraZeneca and beyond continue to pave the way for advancements in medication and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile